Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...

More than 30% of Shire’s (SHPG) total revenue for fiscal 2015 was from its ADHD (attention-deficit/hyperactivity disorder) portfolio. Major drugs in the portfolio ...

Mirum Pharmaceuticals has bought the rights to maralixibat from Shire and raised $120 million to take it into a pair of phase 3 trials next year. The deal reunites some of the management team and ...

The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today, it has ...

After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...

A ex-council worker returned to a Far North council as a contractor and was paid triple their former wage, the state’s ...

There were painters, photographers and pot-throwers. Dabblers, dreamers and arts administrators. Creatives of all persuasions ...

In Beyoncé (2013), Queen Bey's fifth studio album, she showed us why we should all be paying attention to Nigerian writer Chimamanda Ngozi Adichie, whose TED Talk, “We Should All Be Feminists,” was ...